 Vyant Bio NASDAQ:VYNT Inc said it has entered into a collaboration agreement with OrganoTherapeutics to accelerate the discovery of drugs to treat Parkinsons Disease PD. The collaboration brings together the companies expertise in drug discovery using human-derived cells, high-throughput biology and chemistry, and machine learning-based therapeutic design to identify potential drugs to treat PD. 